agilon health Future Growth

Future criteria checks 1/6

agilon health is forecast to grow earnings and revenue by 56.5% and 14.2% per annum respectively. EPS is expected to grow by 56.9% per annum. Return on equity is forecast to be -21.4% in 3 years.

Key information

56.5%

Earnings growth rate

56.9%

EPS growth rate

Healthcare earnings growth20.9%
Revenue growth rate14.2%
Future return on equity-21.4%
Analyst coverage

Good

Last updated19 Nov 2024

Recent future growth updates

Recent updates

agilon health, inc. (NYSE:AGL) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Nov 10
agilon health, inc. (NYSE:AGL) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny

agilon health Plunges On A Poor Prognosis (Rating Downgrade)

Nov 08

Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt

Oct 15
Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt

agilon health: Interesting Business Model, But Volatile And Uncertain

Aug 16

Market Cool On agilon health, inc.'s (NYSE:AGL) Revenues Pushing Shares 34% Lower

Aug 16
Market Cool On agilon health, inc.'s (NYSE:AGL) Revenues Pushing Shares 34% Lower

Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt

Jul 15
Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt

The Market Lifts agilon health, inc. (NYSE:AGL) Shares 41% But It Can Do More

Jun 06
The Market Lifts agilon health, inc. (NYSE:AGL) Shares 41% But It Can Do More

agilon health: Still Not Healthy Enough To Warrant Upside

Apr 19

Is agilon health (NYSE:AGL) Using Too Much Debt?

Apr 04
Is agilon health (NYSE:AGL) Using Too Much Debt?

agilon health: High Growth But Unsustainable Economics

Nov 20

agilon health: Strong Sales Growth, Lacks Remaining Value Drivers

Sep 13

Market Participants Recognise agilon health, inc.'s (NYSE:AGL) Revenues

Jul 17
Market Participants Recognise agilon health, inc.'s (NYSE:AGL) Revenues

agilon health: A Hold Until Margins Are Improved

Jun 30

An Intrinsic Calculation For agilon health, inc. (NYSE:AGL) Suggests It's 35% Undervalued

Jun 06
An Intrinsic Calculation For agilon health, inc. (NYSE:AGL) Suggests It's 35% Undervalued

Is It Time To Consider Buying agilon health, inc. (NYSE:AGL)?

Apr 28
Is It Time To Consider Buying agilon health, inc. (NYSE:AGL)?

Earnings and Revenue Growth Forecasts

NYSE:AGL - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20268,013-90-15513
12/31/20256,845-161-181317
12/31/20246,050-243-186-16417
9/30/20245,594-311-180-135N/A
6/30/20245,280-217-186-141N/A
3/31/20244,866-202-185-143N/A
12/31/20234,316-195-187-156N/A
9/30/20233,630-69-169-145N/A
6/30/20233,188-78-151-129N/A
3/31/20232,789-83-200-168N/A
12/31/20222,388-92-163-131N/A
9/30/20222,481-108-158-130N/A
6/30/20222,245-114-181-152N/A
3/31/20222,074-391-145-131N/A
12/31/20211,521-384-162-148N/A
9/30/20211,692-387-123-113N/A
6/30/20211,546-363-104-98N/A
3/31/20211,340-69-74-68N/A
12/31/20201,218-63-56-53N/A
9/30/20201,095-59-71-68N/A
12/31/2019794-114-108-104N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AGL is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: AGL is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: AGL is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: AGL's revenue (14.2% per year) is forecast to grow faster than the US market (8.9% per year).

High Growth Revenue: AGL's revenue (14.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: AGL is forecast to be unprofitable in 3 years.


Discover growth companies